Design and evaluation of glutathione responsive glycosylated camptothecin nanosupramolecular prodrug

Authors:

Abstract
A novel tumor-targeted glutathione responsive Glycosylated-Camptothecin nanosupramolecular prodrug (CPT-GL NSp) was designed and fabricated via a disulfide bond. The effects of glycoligand with different polarities on solubility, self-assembly, stability, cellular uptake, and glutathione responsive cleaving were explored, and an optimal glycosylated ligand was selected for nanosupramolecular prodrug. It has been found that CPT-GL NSp exhibited higher drug loading than traditional nanoparticles. Among of which maltose modified NSp had the strongest anti-tumor effects than that of glucose and maltotriose. CPT-SS-Maltose had a similar anti-tumor ability to Irinotecan (IR), but the superior performance in solubility, hemolysis, and uptake of HepG2 cells.
Funding Information
  • Fundamental Research Funds for the Provincial Universities of Heilongjiang Province (2017JCZX08)
  • the Scientific Research Fund of Harbin Medical University-Daqing (DQXN201603)
  • Doctor groundbreaking Foundation of Harbin Medical University-Daqing (2019)
  • Technological Innovation Center for Precision Diagnosis and Treatment of Diseases in Cold Regions of Heilongjiang Province-Achievement Transformation and cultivation Project (CXZX-ZXKT02, CXZX-ZXKT03)

This publication has 28 references indexed in Scilit: